TISSUE FACTOR PATHWAY INHIBITOR

被引：43

作者：

NOVOTNY, WF

机构：

[1] Department of Medicine, San Diego Medical Center, University of California, San Diego, CA 92103

来源：

SEMINARS IN THROMBOSIS AND HEMOSTASIS | 1994年 / 20卷 / 01期

关键词：

D O I：

10.1055/s-2007-1001894

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：101 / 108

页数：8

共 105 条

[1]

ABILDGAARD U, 1991, HAEMOSTASIS, V21, P254

[2]

AMERI A, 1992, BLOOD, V79, P3219

[3]

AMERI A, 1991, BLOOD, V78, pA107

[4] CONSERVATION OF TISSUE FACTOR PRIMARY SEQUENCE AMONG 3 MAMMALIAN-SPECIES [J].

ANDREWS, BS ;

REHEMTULLA, A ;

FOWLER, BJ ;

EDGINGTON, TS ;

MACKMAN, N .

GENE, 1991, 98 (02) :265-269

[5] INCREASED FIBRINOLYTIC-ACTIVITY AFTER SURGERY INDUCED BY LOW-DOSE HEPARIN [J].

ARNESEN, H ;

ENGEBRETSEN, LF ;

UGLAND, OM ;

SELJEFLOT, I ;

KIERULF, P .

THROMBOSIS RESEARCH, 1987, 45 (05) :553-559

[6] CULTURED NORMAL HUMAN HEPATOCYTES DO NOT SYNTHESIZE LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR - EVIDENCE THAT ENDOTHELIUM IS THE PRINCIPAL SITE OF ITS SYNTHESIS [J].

BAJAJ, MS ;

KUPPUSWAMY, MN ;

SAITO, H ;

SPITZER, SG ;

BAJAJ, SP .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (22) :8869-8873

[7] INHIBITOR OF THE FACTOR-VIIA-TISSUE FACTOR COMPLEX IS REDUCED IN PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION BUT NOT IN PATIENTS WITH SEVERE HEPATOCELLULAR DISEASE [J].

BAJAJ, MS ;

RANA, SV ;

WYSOLMERSKI, RB ;

BAJAJ, SP .

JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (06) :1874-1878

[8] COMPARATIVE EFFECTS OF ENOXAPARIN AND UNFRACTIONATED HEPARIN IN HEALTHY-VOLUNTEERS ON PROTHROMBIN CONSUMPTION IN WHOLE-BLOOD DURING COAGULATION, AND RELEASE OF TISSUE FACTOR PATHWAY INHIBITOR [J].

BARA, L ;

BLOCH, MF ;

ZITOUN, D ;

SAMAMA, M ;

COLLIGNON, F ;

FRYDMAN, A ;

UZAN, A ;

BOUTHIER, J .

THROMBOSIS RESEARCH, 1993, 69 (05) :443-452

[9]

BAUER KA, 1989, BLOOD, V74, P2007

[10]

BAUER KA, 1990, BLOOD, V76, P731

← 1 2 3 4 5 6 7 8 9 10 →